Phase-3 trial of Covaxin is very crucial, and this is the largest clinically phase-3 trial in India, said Dr. E Venkata Rao, Principal Investigator in the Covaxin human trial to ANI on November 21. He said, "After the success of Phase-1 and 2 of this indigenously developed vaccine by Bharat Biotech....
The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get vaccinated and safeguard themselves from COVID-19 pandemic. Billed as the world's largest vaccination programme, covering the entire length and breadth of the country, the drive aims to first inoculate millions of its healthcare and frontline workers and reach an estimated 3 crore people by the end of its first phase. The mega COVID-19 vaccination drive began in India on January 16 (Saturday).
Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.
Moderate fog engulfed the national capital on the morning of January 24. Bitter cold conditions prevail in parts of north India. Minimum temperature of 4 degrees Celsius is expected in the upcoming week in Delhi. According to the India Meteorological Department, cold wave to severe cold wave is predicted in isolated pockets of Delhi for next 2-3 days. Northern Indian states including the Himalayas can likely to witness rain, thunderstorm and snow during the next few days. IMD's regional Met centre in New Delhi has issued orange alerts over Uttar Pradesh for Jan 24 and across Punjab, Haryana, Chandigarh, and Delhi for Jan 24 and 25.
A scuffle broke out between protesting farmers and officials of Uttarakhand Police on Haridwar-Dehradun Road in Lachhiwala on Jan 23 after the latter tried to stop them from marching towards the Raj Bhavan. Farmers in several states, mainly from Punjab and Haryana, are protesting against the three agricultural laws for nearly two months.
The third-phase trial of Bharat Biotech's Covid-19 vaccine candidate, Covaxin will begin from November 20. Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes..
Credit: HT Digital Content Duration: 02:29Published